(HealthDay)—Azedra (iobenguane) has been approved by the U.S. Food and Drug Administration to treat people 12 and older with rare
Continue reading »![](https://mypharmacynews.com/wp-content/uploads/sites/11/2018/04/NjHM5GAIBkRRZatXItDi.jpg)
mypharmacynews.com
Home »
(HealthDay)—Azedra (iobenguane) has been approved by the U.S. Food and Drug Administration to treat people 12 and older with rare
Continue reading »